Trimethoprim-Sulfamethoxazole Therapy Reduces Failure and Recurrence in Methicillin-Resistant Staphylococcus aureus...

Area of Science:

• Infectious Diseases
• Dermatology
• Pediatric Emergency Medicine

Background:

• Skin abscesses are common pediatric infections requiring surgical drainage.
• Antibiotic selection and duration are critical for successful treatment and preventing recurrence.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a prevalent pathogen in skin and soft tissue infections.

Purpose of the Study:

• To compare the efficacy of 3-day versus 10-day antibiotic courses following surgical drainage of pediatric skin abscesses.
• To evaluate the impact of antibiotic duration on treatment failure and recurrence rates.
• To identify specific pathogens associated with differential treatment outcomes.

Main Methods:

• Randomized controlled trial involving pediatric patients (3 months to 17 years) with uncomplicated skin abscesses.
• Participants received either 3 or 10 days of oral trimethoprim-sulfamethoxazole post-drainage.
• Outcomes assessed included clinical failure at 10-14 days and recurrent infections over 6 months.

Main Results:

• No significant difference in overall treatment failure rates between 3-day and 10-day groups.
• Patients with MRSA infections had higher treatment failure rates with a 3-day antibiotic course (P = .03).
• MRSA-infected patients receiving 3 days of antibiotics were more likely to experience recurrence within one month (P = .046).

Conclusions:

• A 3-day course of trimethoprim-sulfamethoxazole is associated with increased treatment failure and recurrence in pediatric MRSA skin abscesses.
• A 10-day antibiotic regimen is recommended for patients with MRSA skin abscesses after surgical drainage.
• Tailoring antibiotic duration based on pathogen identification, particularly MRSA, is crucial for optimal patient management.